Mazdutide
Mazdutide
Available Vial Sizes: 10 mg in a 3 mL vial
Mazdutide is a synthetic dual agonist peptide targeting both glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptors. It is studied for its potent effects on metabolic regulation, weight management, glucose homeostasis, and energy expenditure in laboratory and preclinical models.
In research settings, mazdutide combines the benefits of GLP-1 receptor activation — such as enhanced insulin secretion (glucose-dependent), slowed gastric emptying, and appetite suppression — with glucagon receptor stimulation, which promotes fat oxidation, increases energy expenditure, and supports reductions in visceral and hepatic fat. This dual mechanism makes it a powerful tool for investigating advanced treatments for obesity, type 2 diabetes, and related metabolic disorders.
This compound is offered strictly for research use only (RUO)
No description available.
Additional information
| Weight | 0.2 lbs |
|---|
Available Certificates
-
BWC - MAZ